Provided by Tiger Trade Technology Pte. Ltd.

ALPHA COGNITION INC

9.10
+0.40004.60%
Post-market: 9.100.00000.00%19:30 EDT
Volume:194.45K
Turnover:1.78M
Market Cap:197.85M
PE:-8.37
High:9.43
Open:8.70
Low:8.70
Close:8.70
52wk High:10.14
52wk Low:4.50
Shares:21.74M
Float Shares:15.06M
Volume Ratio:2.02
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0868
EPS(LYR):-1.1790
ROE:-49.53%
ROA:-30.39%
PB:3.74
PE(LYR):-7.72

Loading ...

Alpha Cognition announces enrollment of first patient in Resolve

TIPRANKS
·
Jun 16

Alpha Cognition Announces First Patient Enrolled in Resolve Phase 4 Study Evaluating Zunveyl® in Patients With Mild to Moderate Alzheimer’s Disease

THOMSON REUTERS
·
Jun 16

Opaleye Management reports Alpha Cognition common share purchase worth $45,845.95

Reuters
·
Jun 16

Opaleye Management acquires Alpha Cognition shares worth $184,037

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Alpha Cognition Inc (ACOG), Zenas BioPharma, Inc. (ZBIO)

TIPRANKS
·
Jun 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11

Opaleye Management acquires Alpha Cognition common shares worth $58,589.64

Reuters
·
Jun 10

Analysts Are Bullish on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Alpha Cognition Inc (ACOG)

TIPRANKS
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-Alpha Cognition surges as study shows Alzheimer’s drug improves cognition, behavior

Reuters
·
Jun 09

Alpha Cognition - Providers Report Delayed or Discontinued Psychotropic Medications in 80% of Zunveyl Patients

THOMSON REUTERS
·
Jun 09

Alpha Cognition - Providers Report Favorable Gi Tolerability and Overall Experience With Zunveyl

THOMSON REUTERS
·
Jun 09

Alpha Cognition Reports Positive Top-Line Results From Beacon Real-World Study of Zunveyl® in Alzheimer’s Disease

THOMSON REUTERS
·
Jun 09

Alpha Cognition - Providers Report Improved Sleep-Related Outcomes in 72% of Zunveyl Patients

THOMSON REUTERS
·
Jun 09

Opaleye Management reports $436,707 Alpha Cognition common-share purchase

Reuters
·
May 30

Alpha Cognition Initiated at Buy by Maxim Group

Dow Jones
·
May 29

Alpha Cognition initiated with a Buy at Maxim

TIPRANKS
·
May 29

Alpha Cognition Inc : Maxim Group Initiates Coverage With Buy Rating; Target Price $12

THOMSON REUTERS
·
May 29

Alpha Cognition Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
May 22